Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vast Therapeutics

Request full access

Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company

Morrisville, United StatesFounded 2017Biotech & Life Sciences

About Vast Therapeutics

Vast Therapeutics is a development stage pharmaceutical company focused on creating therapies to combat resistant bacteria and enhance respiratory health. The company operates in the biotechnology and pharmaceutical markets, targeting patients suffering from severe respiratory diseases. Vast Therapeutics primarily serves healthcare providers and patients who require advanced treatments for conditions like Nontuberculous Mycobacteria (NTM) infections.

The business model revolves around the research and development of innovative drug candidates, such as BIOC11, which has shown promising results in eradicating 99% of NTM in animal models. The company generates revenue through equity financing and aims to commercialize its therapies upon successful clinical trials and regulatory approvals.

Vast Therapeutics is a subsidiary of KNOW Bio, LLC, and benefits from the conglomerate's resources and expertise in biotechnology and MedTech. The company recently secured $30 million in equity financing from Reedy Creek Investments, LLC, which will support its ongoing research and development efforts.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Morrisville, United States
Employees
11
Open positions
None listed
Dealroom signal
66.5/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Jan 2025 $2M — National Institutes of Health ↗
GRANTOther financing Nov 2022 $1.2M — Undisclosed ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Vast Therapeutics website traffic

Latest recorded traffic for Vast Therapeutics is 1.9K monthly website visits, up 93.9% over the last three months. Vast Therapeutics's team grew 0% over the past year.

Latest monthly visits1.9K 3-month web change+93.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vast Therapeutics in the Morrisville ecosystem

Live from Dealroom

The Vast Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • National Institutes of Health

Series A2 investors entered at this stage

  • Victory Pharma
  • Cystic Fibrosis Foundation

Other known investors1 additional known investor

  • University of North Carolina at Chapel Hill
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vast Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vast Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.